- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 317/34 - SulfonesSulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having sulfone or sulfoxide groups and amino groups bound to carbon atoms of six-membered aromatic rings being part of the same non-condensed ring or of a condensed ring system containing that ring
Patent holdings for IPC class C07C 317/34
Total number of patents in this class: 30
10-year publication summary
2
|
2
|
1
|
2
|
3
|
0
|
2
|
3
|
3
|
0
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Allergan, Inc. | 2381 |
4 |
Peloton Therapeutics, Inc. | 37 |
4 |
Northwestern University | 3295 |
3 |
Bayer Cropscience AG | 2096 |
2 |
The General Hospital Corporation | 4652 |
2 |
Id4pharma, LLC | 6 |
2 |
Universidad Autonoma Metropolitana | 22 |
2 |
Hangzhou Phecdamed Co., Ltd. | 12 |
2 |
Syngenta Participations AG | 2125 |
1 |
Syngenta Limited | 472 |
1 |
Bayer AG | 3217 |
1 |
The Regents of the University of Michigan | 4603 |
1 |
Chugai Seiyaku Kabushiki Kaisha | 1316 |
1 |
Creative Therapeutics GmbH | 4 |
1 |
The United States Government AS represented by The Department of Veterans Affairs | 1111 |
1 |
Vanderbilt University | 1824 |
1 |
Grey Wolf Therapeutics Limited | 16 |
1 |
Other owners | 0 |